I understood that they meant MRR and i'm not really doing any calculations - i'm just using their historical data that they've provided.
Revenue for FY18 was 13,143 and op expenses were 19,240 or 146.39% of rev. Revenue guidance is at least 35-40% for FY19 so assuming the high end (40%) let's say that FY19 Rev is 18,400. So if Op expenses are exactly the same as they are for FY18 it would still not break even (this doesn't even consider the cost of sales).
So for the month of December (and presumably onward) assuming their revenue guidance is accurate they Must reduce their op expenses considerably. The only realistic thing i can see them doing is reducing their s&m expense (this grew by 55.34% from FY17-FY18 and accounts for more than 50% of their op expense) but that doesn't make sense for a new and growing company (esp with the acquisition of Zunos).
It could possibly be the acquisition of Zunos and the associated cashflow but this is already accounted for in their revenue guidance (10/09/18). Even if it wasn't and using a 3x cashflow ratio to acquisition price (this is absurdly generous) it would add a further 1.08M to their revenue and assuming the acquisition adds nothing to op expenses it still wouldn't break even.
My figures may be wrong from a MRR point of view and i should probably weight the monthly revenue skewing it to the left but ultimately i don't really understand how they would be revenue neutral by December.
I'm not trying to down ramp or anything here, truthfully my brother is a dev @ BTH so i figured with some insight into the direction of the company i might be able to mosaic my ass to some good profits but i don't really understand the numbers. Admittedly i'm pretty new to this so i could be completely wrong.
Happy to hear anyone's thoughts on this
- Forums
- ASX - By Stock
- BTH
- Ann: Update Revenue growth, operating outcome, customer retention
Ann: Update Revenue growth, operating outcome, customer retention, page-18
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTH (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
0.010(5.71%) |
Mkt cap ! $135.5M |
Open | High | Low | Value | Volume |
18.5¢ | 19.3¢ | 18.0¢ | $893.9K | 4.776M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 774289 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 561202 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23441 | 0.450 |
2 | 15506 | 0.440 |
2 | 31118 | 0.435 |
1 | 10000 | 0.430 |
1 | 15000 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.455 | 8703 | 1 |
0.460 | 44183 | 3 |
0.465 | 5534 | 1 |
0.470 | 101613 | 2 |
0.475 | 24341 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
BTH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online